EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Overexpression of REST Represses the Epithelial–Mesenchymal Transition Process and Decreases the Aggressiveness of Prostate Cancer Cells

Sebastián Indo, Octavio Orellana-Serradell iD, María José Torres iD, Enrique A Castellón iD, Héctor R Contreras iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25063332 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Sebastián Indo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Cellular and Molecular Oncology, Department of Basic and Clinical Oncology, Faculty of Medicine, University of Chile, Santiago 8380453,…. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant, Benzamides, Nitriles. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agencia Nacional de Investigación y Desarrollo, The National Fund for Science and Technology, ANID.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The RE-1 silencing transcription factor (REST) is a repressor factor related to neuroendocrine prostate cancer (PCa) (NEPC), a poor prognostic stage mainly associated with castration-resistant PCa (CRPC). NEPC is associated with cell transdifferentiation and the epithelial–mesenchymal transition (EMT) in cells undergoing androgen deprivation therapy (ADT) and enzalutamide (ENZ). The effect of REST overexpression in the 22rv1 cell line (xenograft-derived prostate cancer) on EMT, migration, invasion, and the viability for ENZ was evaluated. EMT genes, Twist and Zeb1, and the androgen receptor (AR) were evaluated through an RT-qPCR and Western blot in nuclear and cytosolic fractions of REST-overexpressing 22rv1 cells (22rv1-REST). The migratory and invasive capacities of 22rv1-REST cells were evaluated via Transwell® assays with and without Matrigel, respectively, and their viability for enzalutamide via MTT assays. The 22rv1-REST cells showed decreased nuclear levels of Twist, Zeb1, and AR, and a decreased migration and invasion and a lower viability for ENZ compared to the control. Results were expressed as the mean + SD of three independent experiments (Mann–Whitney U test, Kruskal–Wallis, Tukey test). REST behaves like a tumor suppressor, decreasing the aggressiveness of 22rv1 cells, probably through the repression of EMT and the neuroendocrine phenotype. Furthermore, REST could represent a response marker to ENZ in PCa patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsProstatic Neoplasms, Castration-ResistantBenzamidesNitrilesPhenylthiohydantoinMaleHumansAndrogen AntagonistsTranscription FactorsCell Line, TumorReceptors, AndrogenEpithelial-Mesenchymal Transition

Stichwörter der Autor:innen

RE-1 silencing transcription factor (REST)epithelial–mesenchymal transition (EMT)neuroendocrine PCa (NEPC)prostate cancer (PCa)

Substanzen

enzalutamideAndrogen AntagonistsTranscription FactorsReceptors, AndrogenBenzamidesNitrilesPhenylthiohydantoin

Autor:innen und Institutionen

  • Laboratory of Cellular and Molecular Oncology, Department of Basic and Clinical Oncology, Faculty of Medicine, University of Chile, Santiago 8380453, Chile.
  • Center for Cancer Prevention and Control (CECAN), Santiago 8380453, Chile.
  • Millennium Nucleus of Ion Channel-Associated Diseases (MiNICAD), Santiago 8380453, Chile.

ORCID-Profile: Octavio Orellana-Serradell, María José Torres, Enrique A Castellón, Héctor R Contreras

Förderung

  • Agencia Nacional de Investigación y Desarrollo
  • The National Fund for Science and Technology
  • ANID

Zitieren

APA

Indo, S., Orellana-Serradell, O., Torres, M. J., Castellón, E. A., & Contreras, H. R. (2024). Overexpression of REST Represses the Epithelial–Mesenchymal Transition Process and Decreases the Aggressiveness of Prostate Cancer Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25063332

Vancouver

Indo S, Orellana-Serradell O, Torres MJ, Castellón EA, Contreras HR. Overexpression of REST Represses the Epithelial–Mesenchymal Transition Process and Decreases the Aggressiveness of Prostate Cancer Cells. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25063332

BibTeX
@article{Indo2024,
  author = {Indo, Sebastián and Orellana-Serradell, Octavio and Torres, María José and Castellón, Enrique A and Contreras, Héctor R},
  title = {Overexpression of REST Represses the Epithelial–Mesenchymal Transition Process and Decreases the Aggressiveness of Prostate Cancer Cells},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25063332}
}
Kostenlos starten →